Major UK project launched to tackle drug-resistant superbugs with AI

 

The UK is to use artificial intelligence (AI) to tackle the rising numbers of infections that have become resistant to treatment.

 

The project - a collaboration between the Fleming Initiative and the pharmaceutical company GSK - is a battle between superbugs and supercomputers.

 

It aims to speed up the discovery of fresh antibiotics and deliver new ways of killing other threats, including deadly fungal infections.

 

https://www.bbc.co.uk/news/articles/cp97ggrnn35o
 

drug resistant bugs is serious prob

why do we have to click on your links?

why don't you put some effort and summarize it for us?

 

No time to hang around 

@3NUMBAS:  Opening post of this topic has been edited.  Please observe this forum rule when posting:

 

27. You will not post any copyrighted material except as fair use laws apply (as in the case of news articles). Only post a link, the headline and three sentences from the article. Content in the public domain is limited to the same restrictions.

19 hours ago, 3NUMBAS said:

drug resistant bugs is serious prob

 

Antibiotics are more like fire extinguishers — essential even if rarely used. One issue not mentioned in the article is that antibiotics are uniquely unprofitable. This is a major reason why the development pipeline is nearly empty, despite urgent need. Over the past decade, many large pharma companies have shut down their antibiotic divisions, and several small antibiotic-focused biotechs have gone bankrupt shortly after approval because the drugs didn’t sell.

 

This economic reality is also why promising discoveries like Halicin (from 2020) still haven’t reached clinical trials in 2025. The science is exciting — but the incentives are broken.

 

Meanwhile, antimicrobial resistance is projected to cause up to 10 million deaths per year by 2050. Without new economic models, the private sector will continue to avoid antibiotics, no matter how vital they are.